These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 16785528)

  • 1. Analysis of TLR4 polymorphic variants: new insights into TLR4/MD-2/CD14 stoichiometry, structure, and signaling.
    Rallabhandi P; Bell J; Boukhvalova MS; Medvedev A; Lorenz E; Arditi M; Hemming VG; Blanco JC; Segal DM; Vogel SN
    J Immunol; 2006 Jul; 177(1):322-32. PubMed ID: 16785528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory syncytial virus fusion protein-induced toll-like receptor 4 (TLR4) signaling is inhibited by the TLR4 antagonists Rhodobacter sphaeroides lipopolysaccharide and eritoran (E5564) and requires direct interaction with MD-2.
    Rallabhandi P; Phillips RL; Boukhvalova MS; Pletneva LM; Shirey KA; Gioannini TL; Weiss JP; Chow JC; Hawkins LD; Vogel SN; Blanco JC
    mBio; 2012; 3(4):. PubMed ID: 22872782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of soluble form of recombinant extracellular TLR4 domain with MD-2 enables lipopolysaccharide binding and attenuates TLR4-mediated signaling.
    Hyakushima N; Mitsuzawa H; Nishitani C; Sano H; Kuronuma K; Konishi M; Himi T; Miyake K; Kuroki Y
    J Immunol; 2004 Dec; 173(11):6949-54. PubMed ID: 15557191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of a specific interaction between new synthetic antisepsis agents and CD14.
    Piazza M; Yu L; Teghanemt A; Gioannini T; Weiss J; Peri F
    Biochemistry; 2009 Dec; 48(51):12337-44. PubMed ID: 19928913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of functional D299G.T399I polymorphic variant of TLR4 depends more on coexpression of MD-2 than does wild-type TLR4.
    Prohinar P; Rallabhandi P; Weiss JP; Gioannini TL
    J Immunol; 2010 Apr; 184(8):4362-7. PubMed ID: 20212095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host species-specific usage of the TLR4-LPS receptor complex.
    Lizundia R; Sauter KS; Taylor G; Werling D
    Innate Immun; 2008 Aug; 14(4):223-31. PubMed ID: 18669608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of human TLR4 in respiratory syncytial virus-induced NF-κB activation, viral entry and replication.
    Marr N; Turvey SE
    Innate Immun; 2012 Dec; 18(6):856-65. PubMed ID: 22535679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional activity of MD-2 polymorphic variant is significantly different in soluble and TLR4-bound forms: decreased endotoxin binding by G56R MD-2 and its rescue by TLR4 ectodomain.
    Vasl J; Prohinar P; Gioannini TL; Weiss JP; Jerala R
    J Immunol; 2008 May; 180(9):6107-15. PubMed ID: 18424732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exogenous MD-2 confers lipopolysaccharide responsiveness to human corneal epithelial cells with intracellular expression of TLR4 and CD14.
    Lang LL; Wang L; Liu L
    Inflammation; 2011 Oct; 34(5):371-8. PubMed ID: 20700758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel roles in human MD-2 of phenylalanines 121 and 126 and tyrosine 131 in activation of Toll-like receptor 4 by endotoxin.
    Teghanemt A; Re F; Prohinar P; Widstrom R; Gioannini TL; Weiss JP
    J Biol Chem; 2008 Jan; 283(3):1257-1266. PubMed ID: 17977838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique properties of the chicken TLR4/MD-2 complex: selective lipopolysaccharide activation of the MyD88-dependent pathway.
    Keestra AM; van Putten JP
    J Immunol; 2008 Sep; 181(6):4354-62. PubMed ID: 18768894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of mouse MD-2 residues important for forming the cell surface TLR4-MD-2 complex recognized by anti-TLR4-MD-2 antibodies, and for conferring LPS and taxol responsiveness on mouse TLR4 by alanine-scanning mutagenesis.
    Kawasaki K; Nogawa H; Nishijima M
    J Immunol; 2003 Jan; 170(1):413-20. PubMed ID: 12496426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Toll-like receptor 4 polymorphism Asp299Gly but not Thr399Ile influences TLR4 signaling and function.
    Long H; O'Connor BP; Zemans RL; Zhou X; Yang IV; Schwartz DA
    PLoS One; 2014; 9(4):e93550. PubMed ID: 24695807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sialyl residues modulate LPS-mediated signaling through the Toll-like receptor 4 complex.
    Feng C; Stamatos NM; Dragan AI; Medvedev A; Whitford M; Zhang L; Song C; Rallabhandi P; Cole L; Nhu QM; Vogel SN; Geddes CD; Cross AS
    PLoS One; 2012; 7(4):e32359. PubMed ID: 22496731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of tolerance to lipopolysaccharide and mycobacterial components in Chinese hamster ovary/CD14 cells is not affected by overexpression of Toll-like receptors 2 or 4.
    Medvedev AE; Henneke P; Schromm A; Lien E; Ingalls R; Fenton MJ; Golenbock DT; Vogel SN
    J Immunol; 2001 Aug; 167(4):2257-67. PubMed ID: 11490013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Funiculosin variants and phosphorylated derivatives promote innate immune responses via the Toll-like receptor 4/myeloid differentiation factor-2 complex.
    Okamoto N; Mizote K; Honda H; Saeki A; Watanabe Y; Yamaguchi-Miyamoto T; Fukui R; Tanimura N; Motoi Y; Akashi-Takamura S; Kato T; Fujishita S; Kimura T; Ohto U; Shimizu T; Hirokawa T; Miyake K; Fukase K; Fujimoto Y; Nagai Y; Takatsu K
    J Biol Chem; 2017 Sep; 292(37):15378-15394. PubMed ID: 28754693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human TLR4 polymorphism D299G/T399I alters TLR4/MD-2 conformation and response to a weak ligand monophosphoryl lipid A.
    Yamakawa N; Ohto U; Akashi-Takamura S; Takahashi K; Saitoh S; Tanimura N; Suganami T; Ogawa Y; Shibata T; Shimizu T; Miyake K
    Int Immunol; 2013 Jan; 25(1):45-52. PubMed ID: 22962435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential activation of human TLR4 by Escherichia coli and Shigella flexneri 2a lipopolysaccharide: combined effects of lipid A acylation state and TLR4 polymorphisms on signaling.
    Rallabhandi P; Awomoyi A; Thomas KE; Phalipon A; Fujimoto Y; Fukase K; Kusumoto S; Qureshi N; Sztein MB; Vogel SN
    J Immunol; 2008 Jan; 180(2):1139-47. PubMed ID: 18178854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.
    Mishra V; Pathak C
    J Biomol Struct Dyn; 2019 May; 37(8):1968-1991. PubMed ID: 29842849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic lipopolysaccharide transfer cascade to TLR4/MD2 complex via LBP and CD14.
    Kim SJ; Kim HM
    BMB Rep; 2017 Feb; 50(2):55-57. PubMed ID: 28115037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.